{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:39Z","timestamp":1753891899793,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The sequential occurrence of diffuse large B\u2010cell lymphoma (DLBCL) in a patient diagnosed with classical Hodgkin lymphoma (cHL) or vice versa represents a rare situation. In parallel, human leukocyte antigen (HLA) has been studied extensively about rising susceptibility in various lymphomas. Herein, we present clinical characteristics, the outcome and the results of HLA class-I and class-II investigation in patients sequentially diagnosed with the above-mentioned combination of lymphomas. We describe 8 patients (6 males\/2 females) with median age at diagnosis of first and second lymphomas of 45.5 years (range: 25\u201374 years) and 57.5 years (range: 30\u201383 years), respectively. The median interval between the first and the second diagnosis was 6.5 years (range: 4\u201322 years). Regarding HLA investigation, we observed that four of our patients were HLA\u2010DQB1*03:01 positive. Interestingly, three of our patients displaying this HLA allele developed a third lymphoma. Notably, we observed that the HLA profile of three other patients revealed the presence of HLA-B*35:03. Interestingly, both above-mentioned HLA alleles have been associated with autoimmune manifestations. Although the presence of certain HLA alleles in our patients could be coincidental, our results suggest that HLA typing may be a field of investigational interest regarding patients with sequential lymphomas.<\/jats:p>","DOI":"10.3389\/fonc.2025.1586454","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:21:21Z","timestamp":1750742481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Sequential lymphomas: may HLA system play a role in this uncommon phenomenon?"],"prefix":"10.3389","volume":"15","author":[{"given":"Evgenia","family":"Verrou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Diamanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asimina","family":"Fylaktou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Daiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Dalampira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xanthippi","family":"Dimitriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Tara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissavet","family":"Karadrakonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Triantafyllou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aggeliki","family":"Sevastoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthimia","family":"Vlachaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Karampatzakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodosia","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Sinakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Katodritou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Gioula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/(SICI)1098-2825(1999)13:5<199::AID-JCLA1>3.0.CO;2-W","article-title":"Utility of flow cytometry in subtyping composite and sequential lymphoma","volume":"13","author":"Siebert","year":"1999","journal-title":"J Clin Lab Anal"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v193.3","article-title":"Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"193","author":"Eichenauer","year":"2021","journal-title":"Br J Haematol"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.63307","article-title":"Occurrence of secondary non-Hodgkin lymphomas among our classical Hodgkin lymphoma patients: A single-centre experience","author":"Virga","year":"2024","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","first-page":"106479","DOI":"10.1016\/j.leukres.2020.106479","article-title":"Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database","volume":"100","author":"Vassilakopoulos","year":"2021","journal-title":"Leuk Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.v189.2","article-title":"Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma\/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases","volume":"189","author":"Aussedat","year":"2020","journal-title":"Br J Haematol"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.65013","article-title":"Transition from Epstein-Barr virus (EBV)-positive rectal Hodgkin lymphoma to diffuse large B-cell lymphoma in the lung","author":"Di","year":"2024","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.08.002","article-title":"Pathways towards indolent B-cell lymphoma \u2014 Etiology and therapeutic strategies","volume":"31","author":"Van Den Brand","year":"2017","journal-title":"Blood Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2022.08.002","article-title":"HLA homozygosity is associated with Non-Hodgkin lymphoma","volume":"83","author":"Roark","year":"2022","journal-title":"Hum Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1617858","article-title":"The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population","volume":"60","author":"Zhong","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B10","article-title":"Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population","volume":"9","author":"Cui","year":"2024","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1341822","article-title":"HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study","volume":"15","author":"Diamanti","year":"2024","journal-title":"Front Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1100\/2011\/373876","article-title":"Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma","volume":"11","author":"Lu","year":"2011","journal-title":"Sci World J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2104504118","DOI":"10.1073\/pnas.2104504118","article-title":"Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma","volume":"118","author":"Fangazio","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-483420","article-title":"HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma","volume":"122","author":"Alcoceba","year":"2013","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-266775","article-title":"Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology","volume":"115","author":"Wang","year":"2010","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e31865","DOI":"10.1371\/journal.pone.0031865","article-title":"HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China","volume":"7","author":"Huang","year":"2012","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0174457","DOI":"10.1371\/journal.pone.0174457","article-title":"HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients","volume":"12","author":"Fletcher","year":"2017","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104588","article-title":"Association of HLA diversity with the risk of 25 cancers in the UK Biobank","volume":"92","author":"Wang","year":"2023","journal-title":"eBioMedicine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.07.002","article-title":"Role of MHC Class II Genes in the pathogenesis of pemphigoid","volume":"11","author":"Zakka","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/vaccines10020280","article-title":"Significance of HLA haplotypes in two patients with subacute thyroiditis triggered by mRNA-based COVID-19 vaccine","volume":"10","author":"Stasiak","year":"2022","journal-title":"Vaccines"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316686406","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome) \u2013 An update","volume":"26","author":"Watad","year":"2017","journal-title":"Lupus"},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13578-022-00763-0","article-title":"Second Malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders\/diseases","volume":"12","author":"Yu","year":"2022","journal-title":"Cell Biosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0841-x","article-title":"Second Malignant neoplasms after treatment of non-Hodgkin\u2019s lymphoma\u2014a retrospective multinational study of 189 children and adolescents","volume":"35","author":"Attarbaschi","year":"2021","journal-title":"Leukemia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.917115","article-title":"Case report: sequential development of three mature lymphoid neoplasms in a single patient: clonal relationship and molecular insights","volume":"12","author":"Salvetti","year":"2022","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1586454\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T05:21:22Z","timestamp":1750742482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1586454\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":25,"alternative-id":["10.3389\/fonc.2025.1586454"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1586454","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1586454"}}